STOCK TITAN
  1. Home
  2. Sec-filings
  3. AXON
  4. [144] AXON ENTERPRISE, INC. SEC Filing

Axon (AXON) insider Patrick W. Smith plans 10,000-share sale after $21M disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Axon Enterprise, Inc. insider trading plan: An affiliate of Patrick W. Smith has filed to sell 10,000 shares of Axon common stock through UBS Financial Services on or about August 7, 2026, on Nasdaq, with an aggregate market value of $5,263,200.00. The filing also lists prior sales by Smith over the past three months totaling 40,000 shares for combined proceeds exceeding $21.4 million.

Positive

  • None.

Negative

  • None.
Planned shares to be sold 10,000 shares Common stock to be sold through UBS Financial Services on or about August 7, 2026
Aggregate market value of planned sale $5,263,200.00 Value assigned to 10,000 Axon common shares to be sold on Nasdaq
Shares outstanding 81,237,415 shares Axon common shares referenced as outstanding in the filing
Sale on June 4, 2026 20,000 shares for $10,000,000.00 Common stock sale by Patrick W. Smith during past three months
Sale on June 29, 2026 10,000 shares for $5,000,018.00 Common stock sale by Patrick W. Smith during past three months
Sale on July 7, 2026 10,000 shares for $6,437,894.85 Common stock sale by Patrick W. Smith during past three months
Form 144 regulatory
"144: Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Option Exercise financial
"Common | 11/15/2021 | Option Exercise | Issuer"
aggregate market value financial
"Common | UBS Financial Services, Inc. ... | 10000 | 5263200.00"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Nasdaq market
"81237415 | 08/07/2026 | Nasdaq"
The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does Axon (AXON) insider Patrick W. Smith plan to sell under this Form 144?
Patrick W. Smith, via UBS Financial Services, plans to sell 10,000 shares of Axon common stock on or about August 7, 2026 on Nasdaq, with an indicated aggregate market value of $5,263,200.00.

How many AXON shares has Patrick W. Smith sold in the last three months?
Over the past three months, Patrick W. Smith has sold a total of 40,000 shares of Axon common stock in three transactions: 20,000 shares on June 4, 2026, and 10,000 shares each on June 29 and July 7, 2026.

What were the dollar amounts of Patrick W. Smith’s recent AXON share sales?
The disclosed sales totaled $10,000,000.00 on June 4, 2026, $5,000,018.00 on June 29, 2026, and $6,437,894.85 on July 7, 2026, reflecting proceeds from selling Axon common stock.

What aggregate market value is assigned to the planned 10,000 AXON shares sale?
The planned sale of 10,000 Axon common shares is shown with an aggregate market value of $5,263,200.00, based on the pricing information provided alongside the Nasdaq listing details.

How many Axon (AXON) shares are referenced as outstanding in this Form 144?
The Form 144 references 81,237,415 Axon common shares as outstanding, providing context for the relative size of the planned 10,000-share sale compared with the company’s total shares outstanding.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR